Related Experiment Video
Updated: Nov 19, 2025

09:53
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.5K
Artificial intelligence in cancer research: learning at different levels of data granularity
Davide Cirillo1, Iker Núñez-Carpintero1, Alfonso Valencia1,2
1Barcelona Supercomputing Center (BSC), Barcelona, Spain.
Molecular Oncology
|February 3, 2021
Summary
Artificial Intelligence (AI) in cancer research faces challenges due to mixed data sizes and types. This review explores AI solutions for integrating diverse cancer data, emphasizing discriminative and generative models.
Area of Science:
- Oncology and Computational Biology
- Artificial Intelligence in Medicine
- Big Data Analytics in Healthcare
Background:
- Cancer research generates diverse data, from genomic to clinical records, creating a big data environment.
- This data landscape is heterogeneous, featuring a mix of big and small datasets with varying characteristics (sample size, labels, types).
- Integrating these diverse data granularities is crucial for a systems-level understanding of cancer.
Purpose of the Study:
- To review the challenges and limitations of applying Artificial Intelligence (AI) to heterogeneous data granularity in cancer research.
- To explore current solutions and advancements in AI for cancer data integration.
- To highlight the importance of interoperability and the synergy between discriminative and generative AI models.
Main Methods:
- Literature review of AI applications in cancer research focusing on data granularity.
- Analysis of challenges posed by diverse data types, sample sizes, and labels.
- Discussion of AI techniques, including discriminative and generative models, for data integration.
Main Results:
- AI integration faces hurdles due to the coexistence of big and small data resources in cancer research.
- Advancing AI interoperability is essential to address varied data descriptors and levels of granularity.
- Synergistic use of discriminative and generative models offers promising solutions for complex cancer data.
Conclusions:
- Addressing data granularity heterogeneity is key for advancing AI in cancer research.
- Enhanced interoperability and hybrid AI models are crucial for a comprehensive systems view of cancer.
- Future directions involve leveraging AI to bridge data gaps and improve cancer understanding through integrated analysis.
Related Concept Videos
Cancer Survival Analysis
525
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
525
Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Adaptive Mechanisms in Cancer Cells
6.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K

